-+ 0.00%
-+ 0.00%
-+ 0.00%
Hikma Pharmaceuticals Publishes Jefferies Global Healthcare Conference Fireside Chat Transcript
Share
Listen to the news
Hikma Pharmaceuticals Publishes Jefferies Global Healthcare Conference Fireside Chat Transcript
  • Hikma reaffirmed 2026 guidance at the Jefferies Global Healthcare Conference in London on November 18, 2026.
  • Participants included CEO Said Darwazah, strategic planning and global affairs EVP Susan Ringdal, and Jefferies analyst James Vane-Tempest.
  • Injectables revenue is expected to remain flat versus the previous year, below initial low-single-digit growth expectations, with margins of 27%-28%.
  • A major manufacturing contract with a large pharmaceutical company is expected to contribute significantly to growth from 2027.
  • New ready-to-use injectable launches are expected from 2028, with management anticipating a growth acceleration in 2028-2029.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hikma Pharmaceuticals plc published the original content used to generate this news brief on November 19, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending